(2002). A novel interleukin-8 polymorphism is associated with severe systemic lupus erythematosus nephritis.
(2009). ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy.
(2004). Assessing the probability that a positive report is false: an approach for molecular epidemiology studies.
(2007). Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean patients with type 2 diabetes mellitus.
(2000). Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families.
(2007). Association of TGFB1, TNFa, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians.
(2003). Association of transforming growth factor-beta (TGF-b)T869C (Leu 10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese.
(2003). Association of transforming growth factor-beta (TGF-beta) T869C (Leu 10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese.
(2001). Association of transforming growth factor-beta1 T29C polymorphism with the progression of diabetic nephropathy.
(1998). CCR5 promoter polymorphism and HIV-1 disease progression.
(2002). Chemokine receptor genotype is associated with diabetic nephropathy in Japanese with type 2 diabetes.
(2006). Chemotactic cytokine receptor 5 (CCR5) gene promoter polymorphism (59029A/G) is associated with diabetic nephropathy in Japanese patients with type 2 diabetes: A 10-year longitudinal study.
(2006). Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms.
(2008). Correlation of urinary monocyte chemo-attractant protein-1 with other parameters of renal injury in type-II diabetes mellitus.
(1998). Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus.
(2001). Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with type 2 diabetic nephropathy.
(2008). Do inflammatory cytokine genes confer susceptibility to diabetic nephropathy?
(2008). Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians.
(2003). Errors and linkage disequilibrium interact multiplicatively when computing sample sizes for genetic case-control association studies. Pacific Symposium on Biocomputing 490–501. (http://psb.stanford.edu/psb-online/proceedings/psb 03/).
(2003). Ethnic India: A Genomic View, With Special Reference to Peopling and Structure.
(2003). Evaluation of genetic variation and association in the matrix metalloproteinase 9 (MMP9) gene in ESRD patients.
(2003). Genetic variation in the renin–angiotensin system and progression of diabetic nephropathy.
(2007). Genetic variations associated with diabetic nephropathy and type II diabetes in a Japanese population.
(2005). Genetics of diabetic nephropathy in type 2 DM: candidate gene analysis for the pathogenic role of inflammation. Nephrology (Carlton) 10 Suppl:
(2001). Global survey of genetic variation
(2007). Identification of PVT1 as a Candidate Gene for End-Stage Renal Disease in Type 2 Diabetes Using a Pooling-Based Genome-Wide Single Nucleotide Polymorphism Association Study.
(2006). Monocyte chemotactic protein-1 single nucleotide polymorphisms do not confer susceptibility for the development of adult onset polymyositis/dermatomyositis in UK Caucasians. Rheumatology, 1-4, doi:10.1093/rheumatology/ kel359.
(2003). Multifactor dimensionality reduction software for detecting gene–gene and gene-environment interactions.
(2001). Multifactor-Dimensionality Reduction Reveals High-Order Interactions among Estrogen-Metabolism Genes in Sporadic Breast Cancer.
(2009). Navarro-Gonza ´lez JF
(2001). Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial Cytokine Gene Variants in
(2002). People of India: Introduction National Series Anthropological Survey of India. Delhi:
(1983). Polyantigenic expansion of basement membrane constituents in diabetic nephropathy.
(2002). Power and sample size calculations for case-control genetic association tests when errors present: application to single nucleotide polymorphisms.
(2008). Sequence variants in the PLEKHH2 region are associated with diabetic nephropathy in the GoKinD study population.
(1998). TGF-beta1 gene mutations in insulin-dependent diabetes mellitus and diabetic nephropathy.
(2004). The future of association studies: gene based analysis and replication.
(2008). The role of chemokines and chemokine receptors in diabetic nephropathy.
(2008). The role of inflammatory cytokines in diabetic nephropathy.
(1996). The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats.
(2002). Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy.
(2006). Urinary tumour necrosis factoralpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
(2005). What makes a good genetic association study?